Clinical Trial Update: Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain [Phase 2]

View source ↗

Summary

A completed Phase 2 safety and efficacy trial evaluating a treatment for diabetic neuropathic pain in patients with diabetic neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuralgia
• Diabetic Neuropathy
• Diabetic Polyneuropathy

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Diabetic Neuralgia, Diabetic Neuropathies | Phase 2 | Status: COMPLETED